rel-Delequamine
rel-Delequamine (rel-RS-15385-197) is an orally active, brain-penetrant, potent and selective M2-adrenoceptor antagonist and α2-adrenoceptor antagonist. rel-Delequamine has a pKi of 9.45 for α2-adrenoceptors in the rat cortex. rel-Delequamine augments K+-evoked release of noradrenaline with an EC50 of 1 nM.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 119813-87-5
- Formel: C18H26N2O3S
- Molecular Weight:350.48
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle Adrenergic Receptor Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Chemical Information
-
CAS. Nr. 119813-87-5
-
Molecular Weight 350.48
-
Formel C18H26N2O3S
-
SMILES
O=S(N1CCC[C@@]2(CN([C@]3(C[C@]12[H])[H])CCC4=C3C=CC(OC)=C4)[H])(C)=O
-
Synonyms
rel-RS-15385-197
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
[1]. Brown CM, et al. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist. Br J Pharmacol. 1993 Feb;108(2):516-25. [Content Brief]
[2]. Redfern WS, et al. Modulation of central noradrenergic function by RS-15385-197. Br J Pharmacol. 1993 Feb;108(2):526-33. [Content Brief]
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)